Navigation Links
Global Bioenergies is Setting-Up its Scientific Advisory Board and Obtains Proof of Concept for a Bioprocess Generating Gaseous Hydrocarbons From Renewable Resources
Date:10/13/2009

EVRY, October 13 /PRNewswire/ -- Philippe Marliere, cofounder and initiator of the project, has announced the establishment of the scientific advisory board:

    - Dr. Bernard Badet heads a research group at the Institut de
      Chimie des Substances Naturelles (Gif-sur-Yvette, France) that is
      interested in the understanding of the enzyme mechanism towards the
      development of chemical tools for diagnostic and therapeutic purposes.

    - Prof. Donald Hilvert heads a research group at the ETH
      Zurich (Zurich, Switzerland). His research program focuses on
      understanding how enzymes work and evolve and on mimicking the
      properties of these remarkable catalysts in the laboratory.

    - Prof. Jean-Marc Paris led the R&D division responsible for
      antibiotic discovery at Rhone Poulenc Rorer before joining Rhodia,
      where he worked as Scientific Director for organic chemistry and
      biotechnologies. He is honorary Professor at the Ecole Nationale
      Superieure de Chimie de Paris.

    - Prof. Dieter Soll heads a research laboratory at Yale
      University in New Haven (Connecticut, USA), investigating the
      biocatalytic and evolutionary basis of protein biosynthesis. Prof. Soll
      is a member of the US Academy of Sciences.

    - Dr. Jean Weissenbach is the Director of Genoscope, the
      French genome sequencing center, which he founded in 1997. Now part of
      the Genomics Institute of the CEA, Genoscope is searching new enzyme
      activities using genomics and large scale experimentation. Dr.
      Weissenbach is a member of the French Academy of Sciences.

Global Bioenergies, located on the Genopole campus close to Paris, has today announced the proof-of-concept of a synthetic metabolic pathway for producing isobutene, a key building block that can be converted into transportation fuels, polymers and various commodity chemicals.

Macha Anissimova, Head of Research, said "We are very proud to have reached this key milestone in advance on schedule. We have benefited from the assistance of Genoscope and of the analytical chemistry platform of Evry-Val d'Essonne University. The bioproduction of a gaseous hydrocarbon will make it possible to obtain pure products at high yield and low cost.".

According to Prof. Dieter Soll, "The data on isobutene formation presented by Global Bioenergies are convincing, and I am now impatient to see the process optimized and scaled up."

"Development of such an artificial metabolic pathway represents a signal accomplishment with enormous implications. Standard technologies for enzyme and metabolic engineering can now be applied to transform this proof of concept into a viable industrial process," added Prof. Donald Hilvert.

Marc Delcourt, cofounder and CEO of the company concludes: "We are now focusing on industrializing the process, which will be financed through a second round currently in preparation."

Please visit our new web site: http://www.global-bioenergies.com

SOURCE Global Bioenergies


'/>"/>
SOURCE Global Bioenergies
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Systagenix Announces Formation of New Global Medical Advisory Board to Support Future Clinical Advances in Wound Care
2. Global Pharmaceutical Company Awards Comprehensive Cardiac Safety Study to iCardiac
3. Biotechnology Can Address Global Mega Trends, DuPont Leader Says
4. Environmental & Economic Factors Drives Global Demand for Pharmaceutical leak Testing and Deblistering
5. Global Regulators to Discuss Benefit-Risk Approaches of Medicinal Products at DIA Workshop
6. Global Biofuels Growth to Double by 2015
7. DIA Conference to Provide FDA, EMEA, Health Canada, Emerging Regions, NGO, and Industry Perspectives on Global Vaccine Development
8. Global Public Health the Focus of Scientific Conference
9. Global Med Technologies(R) Signs Binding LOI With European Company for Breakthrough Transfusion Safety RFID Product
10. Cell Therapeutics Added to the NASDAQ OMX Global Biotechnology Index
11. Fortebio, Inc. to Present at UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... (PRWEB) , ... August 22, 2017 , ... Mettler-Toledo, one ... its V2630 vision inspection system . This turnkey system inspects labels, prints, and ... to the requirements of different production lines and extended as needed. , The ...
(Date:8/23/2017)... ... ... Having proven that its Disruptor™ technology is more than ... Cell Technologies® (GCT®), has turned its attention to the lucrative fruit sugar ... ushering in a new era of modern, cost effective and more natural processing ...
(Date:8/23/2017)... MN (PRWEB) , ... August 23, 2017 , ... ... by health systems and academic medical centers. The network provides members nationally scaled ... limited-distribution drugs and biologics and restrictive payer agreements so members can provide continuity ...
(Date:8/22/2017)... ... August 22, 2017 , ... KBioBox is pleased ... technology, the extended GUIDE-Seq ananlysis. KBioBox has adapted their core technology and direct ... scientists with easy to understand reports, extended indel analysis, and translocation analysis. , ...
Breaking Biology Technology:
(Date:4/5/2017)... KEY FINDINGS The global market for stem ... 25.76% during the forecast period of 2017-2025. The rise ... growth of the stem cell market. Download ... The global stem cell market is segmented on the ... cell market of the product is segmented into adult ...
(Date:3/30/2017)... 2017  On April 6-7, 2017, Sequencing.com will host ... hackathon at Microsoft,s headquarters in Redmond, ... on developing health and wellness apps that provide a ... Genome is the first hackathon for personal genomics ... companies in the genomics, tech and health industries are ...
(Date:3/29/2017)... 29, 2017  higi, the health IT company that ... North America , today announced a Series B ... of EveryMove. The new investment and acquisition accelerates higi,s ... to transform population health activities through the collection and ... higi collects and secures data today on behalf ...
Breaking Biology News(10 mins):